Hagens, Marloes H. J. http://orcid.org/0000-0002-7115-6833
Golla, Sandeep S. V.
Janssen, Bieneke
Vugts, Danielle J.
Beaino, Wissam
Windhorst, Albert D.
O’Brien-Brown, James
Kassiou, Michael
Schuit, Robert C.
Schwarte, Lothar A.
de Vries, Helga E.
Killestein, Joep
Barkhof, Frederik
van Berckel, Bart N. M.
Lammertsma, Adriaan A.
Funding for this research was provided by:
Merck KGaA (GMSI)
Stichting MS Research (14-358e)
Article History
Received: 13 March 2019
Accepted: 24 September 2019
First Online: 8 November 2019
Compliance with ethical standards
:
: HEV has accepted speaker fees from Merck. JK has accepted speaker and consultancy fees from Merck, Teva, Biogen, Genzyme, Roche, and Novartis. FB is supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre and serves as a consultant for Bayer-Schering Pharma, Sanofi-Aventis, Genzyme, Biogen-Idec, Teva, Novartis, Roche, Synthon BV, and Janssen Research. All other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Medical Ethics Review Board of the Amsterdam UMC, location VUmc (registered under number 2016.548) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.